Mechanisms driving the ageing heart

Experimental Gerontology

Volumn 109, Issue , 2018, Pages 5-15

  Anderson, Rhys ^a,b   Richardson, Gavin D ^c   Passos, João F ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

DNA damage response; Mitochondria; Reactive oxygen species; Senescence; Telomeres

Indexed keywords

ATM PROTEIN; FREE RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

AGING; CARDIOVASCULAR DISEASE; CELL AGING; CELL CYCLE ARREST; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA DAMAGE RESPONSE; DNA REPAIR; GENE MUTATION; HEART; HUMAN; MITOCHONDRION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SENESCENCE; SOMATIC CELL; TELOMERE; ANIMAL; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; CELLULAR SENESCENCE; DNA DAMAGE; DNA REPAIR; HEART; HUMANS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; TELOMERE;

EID: 85034842028     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2017.10.015     Document Type: Review

References (196)

1. Acosta, J.C., Banito, A. et al., A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15:8 (2013), 978–990.
2. Adams, M.J., Hardenbergh, P.H. et al., Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 45:1 (2003), 55–75.
3. Alter, B.P., Rosenberg, P.S. et al., Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 97:3 (2012), 353–359.
4. Andziak, B., O'Connor, T.P. et al., High oxidative damage levels in the longest-living rodent, the naked mole-rat. Aging Cell 5:6 (2006), 463–471.
5. Anisimov, V.N., Egorov, M.V. et al., Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging (Albany NY) 3:11 (2011), 1110–1119.
6. Baar, M.P., Brandt, R.M. et al., Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169:1 (2017), 132–147 (e116).
7. Bae, N.S., Baumann, P., A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 26:3 (2007), 323–334.
8. Baker, D.J., Wijshake, T. et al., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:7372 (2011), 232–236.
9. Baker, D.J., Childs, B.G. et al., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530:7589 (2016), 184–189.
10. Bakkenist, C.J., Kastan, M.B., DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:6922 (2003), 499–506.
11. Ballinger, S.W., Patterson, C. et al., Mitochondrial integrity and function in atherogenesis. Circulation 106:5 (2002), 544–549.
12. Bandy, B., Davison, A.J., Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?. Free Radic. Biol. Med. 8:6 (1990), 523–539.
13. Barja, G., Herrero, A., Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J. 14:2 (2000), 312–318.
14. Basel-Vanagaite, L., Dokal, I. et al., Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations. Haematologica 93:6 (2008), 943–944.
15. Bednarek, D., González-Rosa, J.M. et al., Telomerase is essential for zebrafish heart regeneration. Cell Rep. 12:10 (2015), 1691–1703.
16. Bell, E.L., Klimova, T.A. et al., Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol. Cell. Biol. 27:16 (2007), 5737–5745.
17. Bergmann, O., Bhardwaj, R.D. et al., Evidence for cardiomyocyte renewal in humans. Science 324:5923 (2009), 98–102.
18. Bergmann, O., Zdunek, S. et al., Dynamics of cell generation and turnover in the human heart. Cell 161:7 (2015), 1566–1575.
19. Blackburn, E.H., Switching and signaling at the telomere. Cell 106:6 (2001), 661–673.
20. Blasco, M.A., Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6:8 (2005), 611–622.
21. Bodnar, A.G., Ouellette, M. et al., Extension of life-span by introduction of telomerase into normal human cells. Science 279:5349 (1998), 349–352.
22. Braunersreuther, V., Jaquet, V., Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr. Pharm. Biotechnol. 13:1 (2012), 97–114.
23. Brunk, U.T., Terman, A., Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33:5 (2002), 611–619.
24. Bryan, T.M., Marusic, L. et al., The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 6:6 (1997), 921–926.
25. Buffenstein, R., Edrey, Y.H. et al., The oxidative stress theory of aging: embattled or invincible? Insights from non-traditional model organisms. Age (Dordr.) 30:2–3 (2008), 99–109.
26. Carson, C.T., Schwartz, R.A. et al., The Mre11 complex is required for ATM activation and the G(2)/M checkpoint. EMBO J. 22:24 (2003), 6610–6620.
27. Cervelli, T., Borghini, A. et al., DNA damage and repair in atherosclerosis: current insights and future perspectives. Int. J. Mol. Sci. 13:12 (2012), 16929–16944.
28. Chang, J., Wang, Y. et al., Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22:1 (2016), 78–83.
29. Cheng, Z., Ito, S. et al., Characteristics of cardiac aging in C57BL/6 mice. Exp. Gerontol. 48:3 (2013), 341–348.
30. Cheresh, P., Kim, S.J. et al., Oxidative stress and pulmonary fibrosis. Biochim. Biophys. Acta 1832:7 (2013), 1028–1040.
31. Childs, B.G., Baker, D.J. et al., Senescence and apoptosis: dueling or complementary cell fates?. EMBO Rep. 15:11 (2014), 1139–1153.
32. Coppe, J.P., Patil, C.K. et al., Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6:12 (2008), 2853–2868.
33. Correia-Melo, C., Marques, F.D. et al., Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J. 35:7 (2016), 724–742.
34. Corsetti, G., Pasini, E. et al., Morphometric changes induced by amino acid supplementation in skeletal and cardiac muscles of old mice. Am. J. Cardiol. 101:11A (2008), 26E–34E.
35. Cui, H., Kong, Y. et al., Oxidative stress, mitochondrial dysfunction, and aging. J. Signal Transduct., 2012, 2012, 646354.
36. d'Adda di Fagagna, F., Reaper, P.M. et al., A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:6963 (2003), 194–198.
37. Dai, D.F., Santana, L.F. et al., Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119:21 (2009), 2789–2797.
38. Darby, S., McGale, P. et al., Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ 326:7383 (2003), 256–257.
39. de Boer, R.A., van Veldhuisen, D.J. et al., Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J. Card. Fail. 6:4 (2000), 330–337.
40. Demaria, M., Ohtani, N. et al., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31:6 (2014), 722–733.
41. Dimri, G.P., Lee, X. et al., A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:20 (1995), 9363–9367.
42. Ding, H., Yan, F. et al., Association between previously identified loci affecting telomere length and coronary heart disease (CHD) in Han Chinese population. Clin. Interv. Aging 9 (2014), 857–861.
43. Doksani, Y., de Lange, T., Telomere-internal double-strand breaks are repaired by homologous recombination and PARP1/Lig3-dependent end-joining. Cell Rep. 17:6 (2016), 1646–1656.
44. Doksani, Y., Wu, J.Y. et al., Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. Cell 155:2 (2013), 345–356.
45. Doonan, R., McElwee, J.J. et al., Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 22:23 (2008), 3236–3241.
46. Dupre-Crochet, S., Erard, M. et al., ROS production in phagocytes: why, when, and where?. J. Leukoc. Biol. 94:4 (2013), 657–670.
47. Edrey, Y.H., Hanes, M. et al., Successful aging and sustained good health in the naked mole rat: a long-lived mammalian model for biogerontology and biomedical research. ILAR J. 52:1 (2011), 41–53.
48. El'darov Ch, M., Vays, V.B. et al., Morphometric examination of mitochondrial ultrastructure in aging cardiomyocytes. Biochemistry (Mosc) 80:5 (2015), 604–609.
49. Elmore, S., Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35:4 (2007), 495–516.
50. Falck, J., Coates, J. et al., Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434:7033 (2005), 605–611.
51. Farr, J.N., Fraser, D.G. et al., Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31:11 (2016), 1920–1929.
52. Freund, A., Patil, C.K. et al., p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30:8 (2011), 1536–1548.
53. Friedman, J.R., Nunnari, J., Mitochondrial form and function. Nature 505:7483 (2014), 335–343.
54. Fumagalli, M., Rossiello, F. et al., Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 14:4 (2012), 355–365.
55. Fuster, J.J., Andres, V., Telomere biology and cardiovascular disease. Circ. Res. 99:11 (2006), 1167–1180.
56. Galimov, E.R., The role of p66shc in oxidative stress and apoptosis. Acta Nat. 2:4 (2010), 44–51.
57. Garinis, G.A., van der Horst, G.T. et al., DNA damage and ageing: new-age ideas for an age-old problem. Nat. Cell Biol. 10:11 (2008), 1241–1247.
58. Gartel, A.L., Tyner, A.L., The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1:8 (2002), 639–649.
59. Giorgio, M., Migliaccio, E. et al., Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122:2 (2005), 221–233.
60. Goffart, S., von Kleist-Retzow, J.-C. et al., Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc. Res. 64:2 (2004), 198–207.
61. Griffith, J.D., Comeau, L. et al., Mammalian telomeres end in a large duplex loop. Cell 97:4 (1999), 503–514.
62. Harley, C.B., Futcher, A.B. et al., Telomeres shorten during ageing of human fibroblasts. Nature 345:6274 (1990), 458–460.
63. Harman, D., Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11:3 (1956), 298–300.
64. Harman, D., The biologic clock: the mitochondria?. J. Am. Geriatr. Soc. 20:4 (1972), 145–147.
65. Hayflick, L., The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37 (1965), 614–636.
66. Hayflick, L., Moorhead, P.S., The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961), 585–621.
67. Hepple, R.T., Baker, D.J. et al., Caloric restriction protects mitochondrial function with aging in skeletal and cardiac muscles. Rejuvenation Res. 9:2 (2006), 219–222.
68. Herbig, U., Jobling, W.A. et al., Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14:4 (2004), 501–513.
69. Hewitt, G., Jurk, D. et al., Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun., 3, 2012, 708.
70. Hill, M.F., Singal, P.K., Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am. J. Pathol. 148:1 (1996), 291–300.
71. Holmstrom, K.M., Finkel, T., Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 15:6 (2014), 411–421.
72. Hoshino, A., Mita, Y. et al., Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat. Commun., 4, 2013, 2308.
73. Hsieh, P.C., Segers, V.F. et al., Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13:8 (2007), 970–974.
74. Hubackova, S., Krejcikova, K. et al., IL1- and TGFbeta-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine ‘bystander senescence’. Aging (Albany NY) 4:12 (2012), 932–951.
75. Iannello, A., Raulet, D.H., Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harb. Symp. Quant. Biol. 78 (2013), 249–257.
76. Iannello, A., Thompson, T.W. et al., p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J. Exp. Med. 210:10 (2013), 2057–2069.
77. Ide, T., Tsutsui, H. et al., Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86:2 (2000), 152–157.
78. Iglewski, M., Hill, J.A. et al., Mitochondrial fission and autophagy in the normal and diseased heart. Curr. Hypertens. Rep. 12:6 (2010), 418–425.
79. Ishikawa, K., Takenaga, K. et al., ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:5876 (2008), 661–664.
80. Jafri, M.A., Ansari, S.A. et al., Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med., 8, 2016, 69.
81. Jastroch, M., Divakaruni, A.S. et al., Mitochondrial proton and electron leaks. Essays Biochem. 47 (2010), 53–67.
82. Judge, S., Jang, Y.M. et al., Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J. 19:3 (2005), 419–421.
83. Jurk, D., Wang, C. et al., Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11:6 (2012), 996–1004.
84. Kang, T.W., Yevsa, T. et al., Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479:7374 (2011), 547–551.
85. Karbowski, M., Kurono, C. et al., Free radical-induced megamitochondria formation and apoptosis. Free Radic. Biol. Med. 26:3–4 (1999), 396–409.
86. Kastan, M.B., DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes memorial award lecture. Mol. Cancer Res. 6:4 (2008), 517–524.
87. Kaul, Z., Cesare, A.J. et al., Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep. 13:1 (2012), 52–59.
88. Kovacic, J.C., Moreno, P. et al., Cellular senescence, vascular disease, and aging: part 1 of a 2-part review. Circulation 123:15 (2011), 1650–1660.
89. Krizhanovsky, V., Yon, M. et al., Senescence of activated stellate cells limits liver fibrosis. Cell 134:4 (2008), 657–667.
90. Krtolica, A., Parrinello, S. et al., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U. S. A. 98:21 (2001), 12072–12077.
91. Kuilman, T., Michaloglou, C. et al., Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:6 (2008), 1019–1031.
92. LaRocca, T.J., Hearon, C.M. et al., Mitochondrial quality control and age-associated arterial stiffening. Exp. Gerontol., 2014, 78–82.
93. Lawless, C., Wang, C. et al., Quantitative assessment of markers for cell senescence. Exp. Gerontol. 45:10 (2010), 772–778.
94. Lebovitz, R.M., Zhang, H. et al., Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 93:18 (1996), 9782–9787.
95. Lee, A.C., Fenster, B.E. et al., Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274:12 (1999), 7936–7940.
96. Lee, S.-J., Hwang, A.B. et al., Inhibition of respiration extends C. elegans' lifespan via reactive oxygen species that increase HIF-1 activity. Curr. Biol. 20:23 (2010), 2131–2136.
97. Lemasters, J.J., Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 8:1 (2005), 3–5.
98. Little, M.P., Exposure to radiation and higher risk of circulatory disease. BMJ, 340, 2010, b4326.
99. Liu, X., Chua, C.C. et al., Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am. J. Physiol. Heart Circ. Physiol. 286:3 (2004), H933–939.
100. Logan, A., Shabalina, I.G. et al., In vivo levels of mitochondrial hydrogen peroxide increase with age in mtDNA mutator mice. Aging Cell 13:4 (2014), 765–768.
101. Lopez-Lluch, G., Irusta, P.M. et al., Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 43:9 (2008), 813–819.
102. Lowe, D., Raj, K., Premature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression. Aging Cell 13:5 (2014), 900–910.
103. Luo, X., Kraus, W.L., On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 26:5 (2012), 417–432.
104. Macip, S., Igarashi, M. et al., Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 21:9 (2002), 2180–2188.
105. Macip, S., Igarashi, M. et al., Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23:23 (2003), 8576–8585.
106. Maejima, Y., Adachi, S. et al., Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage. Aging Cell 7:2 (2008), 125–136.
107. Malliaras, K., Zhang, Y. et al., Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol. Med. 5:2 (2013), 191–209.
108. Mao, P., Liu, J. et al., Homologous recombination-dependent repair of telomeric DSBs in proliferating human cells. Nat. Commun., 7, 2016, 12154.
109. Maubaret, C.G., Salpea, K.D. et al., Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease. PLoS One, 8(12), 2013, e83122.
110. McCubrey, J.A., Lahair, M.M. et al., Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal. 8:9–10 (2006), 1775–1789.
111. Metcalfe, J.A., Parkhill, J. et al., Accelerated telomere shortening in ataxia telangiectasia. Nat. Genet. 13:3 (1996), 350–353.
112. Migliaccio, E., Giorgio, M. et al., The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402:6759 (1999), 309–313.
113. Minamino, T., Orimo, M. et al., A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15:9 (2009), 1082–1087.
114. Mittal, M., Siddiqui, M.R. et al., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal. 20:7 (2014), 1126–1167.
115. Mone, S.M., Gillman, M.W. et al., Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. Pediatrics 113:4 Suppl (2004), 1058–1069.
116. Mugge, A., The role of reactive oxygen species in atherosclerosis. Z. Kardiol. 87:11 (1998), 851–864.
117. Munoz-Espin, D., Serrano, M., Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15:7 (2014), 482–496.
118. Munoz-Espin, D., Canamero, M. et al., Programmed cell senescence during mammalian embryonic development. Cell 155:5 (2013), 1104–1118.
119. Nakao, Y., Yang, X. et al., Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br. J. Cancer 75:10 (1997), 1410–1416.
120. Narita, M., Nunez, S. et al., Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:6 (2003), 703–716.
121. Navarro, A., Boveris, A., The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292:2 (2007), C670–686.
122. Nelson, G., Wordsworth, J. et al., A senescent cell bystander effect: senescence-induced senescence. Aging Cell 11:2 (2012), 345–349.
123. Nunnari, J., Suomalainen, A., Mitochondria: in sickness and in health. Cell 148:6 (2012), 1145–1159.
124. O'Driscoll, M., Diseases associated with defective responses to DNA damage. Cold Spring Harb. Perspect. Biol., 4(12), 2012, a012773.
125. Ogrodnik, M., Miwa, S. et al., Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun., 8, 2017, 15691.
126. Olovnikov, A.M., Principle of marginotomy in template synthesis of polynucleotides. Dokl. Akad. Nauk SSSR 201:6 (1971), 1496–1499.
127. Olovnikov, A.M., A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41:1 (1973), 181–190.
128. Pacher, P., Cziraki, A. et al., Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem. Pharmacol. 64:12 (2002), 1785–1791.
129. Packer, L., Oxidative stress, antioxidants, aging and disease. Cutler, R.G., Packer, L., Bertram, J., Mori, A., (eds.) Oxidative Stress and Aging, 1995, Birkhäuser Basel, Basel, 1–14.
130. Paravicini, T.M., Touyz, R.M., NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31:Suppl. 2 (2008), S170–180.
131. Passos, J.F., Saretzki, G. et al., Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol., 5(5), 2007, e110.
132. Passos, J.F., Nelson, G. et al., Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol., 6, 2010, 347.
133. Perez, V.I., Van Remmen, H. et al., The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 8:1 (2009), 73–75.
134. Piantadosi, C.A., Suliman, H.B., Redox regulation of mitochondrial biogenesis. Free Radic. Biol. Med. 53:11 (2012), 2043–2053.
135. Pilegaard, H., Saltin, B. et al., Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J. Physiol. 546:Pt 3 (2003), 851–858.
136. Preston, C.C., Oberlin, A.S. et al., Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech. Ageing Dev. 129:6 (2008), 304–312.
137. Puente, B.N., Kimura, W. et al., The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157:3 (2014), 565–579.
138. Qiang, W., Weiqiang, K. et al., Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Exp. Mol. Med. 39:4 (2007), 535–543.
139. Radak, Z., Chung, H.Y. et al., Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology 6:1 (2005), 71–75.
140. Rao, K.S., Genomic damage and its repair in young and aging brain. Mol. Neurobiol. 7:1 (1993), 23–48.
141. Reznick, R.M., Zong, H. et al., Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab. 5:2 (2007), 151–156.
142. Richardson, G.D., Breault, D. et al., Telomerase expression in the mammalian heart. FASEB J. 26:12 (2012), 4832–4840.
143. Richardson, G.D., Laval, S. et al., Cardiomyocyte regeneration in the mdx mouse model of nonischemic cardiomyopathy. Stem Cells Dev. 24:14 (2015), 1672–1679.
144. Richter, C., Park, J.W. et al., Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U. S. A. 85:17 (1988), 6465–6467.
145. Riley, P.A., Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. J. Radiat. Biol. 65:1 (1994), 27–33.
146. Ristow, M., Schmeisser, K., Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose-Response 12:2 (2014), 288–341.
147. Rodriguez, R., Meuth, M., Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol. Biol. Cell 17:1 (2006), 402–412.
148. Roos, C.M., Zhang, B. et al., Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell 15:5 (2016), 973–977.
149. Rouse, J., Jackson, S.P., Interfaces between the detection, signaling, and repair of DNA damage. Science 297:5581 (2002), 547–551.
150. Rudolph, K.L., Chang, S. et al., Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:5 (1999), 701–712.
151. Samper, E., Flores, J.M. et al., Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc(−/−) mice with short telomeres. EMBO Rep. 2:9 (2001), 800–807.
152. Sato, M., Sato, K., Maternal inheritance of mitochondrial DNA by diverse mechanisms to eliminate paternal mitochondrial DNA. Biochim. Biophys. Acta 1833:8 (2013), 1979–1984.
153. Schriner, S.E., Linford, N.J. et al., Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308:5730 (2005), 1909–1911.
154. Senyo, S.E., Lee, R.T. et al., Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation. Stem Cell Res. 13:3 Pt B (2014), 532–541.
155. Serrano, M., Lin, A.W. et al., Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:5 (1997), 593–602.
156. Severino, J., Allen, R.G. et al., Is beta-galactosidase staining a marker of senescence in vitro and in vivo?. Exp. Cell Res. 257:1 (2000), 162–171.
157. Shapiro, G.I., Edwards, C.D. et al., Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 55:3 (1995), 505–509.
158. Shimizu, Y., Kodama, K. et al., Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ, 340, 2010, b5349.
159. Shizukuda, Y., Matoba, S. et al., Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol. Cell. Biochem. 273:1–2 (2005), 25–32.
160. Sitte, N., Merker, K. et al., Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic. Biol. Med. 28:5 (2000), 701–708.
161. Spallarossa, P., Altieri, P. et al., Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. Am. J. Physiol. Heart Circ. Physiol. 297:6 (2009), H2169–2181.
162. Storer, M., Mas, A. et al., Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155:5 (2013), 1119–1130.
163. St-Pierre, J., Drori, S. et al., Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127:2 (2006), 397–408.
164. Su, Y., Swift, M., Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann. Intern. Med. 133:10 (2000), 770–778.
165. Swanson, E.C., Manning, B. et al., Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence. J. Cell Biol. 203:6 (2013), 929–942.
166. Szabo, G., Liaudet, L. et al., Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc. Res. 61:3 (2004), 471–480.
167. Taneike, M., Yamaguchi, O. et al., Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6:5 (2010), 600–606.
168. Taylor, C.W., Povall, J.M. et al., Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int. J. Radiat. Oncol. Biol. Phys. 72:2 (2008), 501–507.
169. Taylor, C.W., Nisbet, A. et al., Cardiac doses from Swedish breast cancer radiotherapy since the 1950s. Radiother. Oncol. 90:1 (2009), 127–135.
170. Terman, A., Kurz, T. et al., Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial–lysosomal axis theory of aging. Antioxid. Redox Signal. 12:4 (2010), 503–535.
171. Torella, D., Rota, M. et al., Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 94:4 (2004), 514–524.
172. Trifunovic, A., Hansson, A. et al., Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl. Acad. Sci. U. S. A. 102:50 (2005), 17993–17998.
173. Tsutsui, H., Ide, T. et al., Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. Cardiovasc. Res. 49:1 (2001), 103–109.
174. 2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am. J. Physiol. Heart Circ. Physiol. 293:1 (2007), H37–47.
175. Valavanidis, A., Vlachogianni, T. et al., Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health 6:2 (2009), 445–462.
176. van Deursen, J.M., The role of senescent cells in ageing. Nature 509:7501 (2014), 439–446.
177. Villeneuve, C., Guilbeau-Frugier, C. et al., p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by Monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid. Redox Signal. 18:1 (2013), 5–18.
178. von Zglinicki, T., Oxidative stress shortens telomeres. Trends Biochem. Sci. 27:7 (2002), 339–344.
179. von Zglinicki, T., Saretzki, G. et al., Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res. 220:1 (1995), 186–193.
180. von Zglinicki, T., Pilger, R. et al., Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic. Biol. Med. 28:1 (2000), 64–74.
181. Vulliamy, T., Marrone, A. et al., Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36:5 (2004), 447–449.
182. Wang, D., Malo, D. et al., Elevated mitochondrial reactive oxygen species generation affects the immune response via hypoxia-inducible factor-1alpha in long-lived Mclk1 +/− mouse mutants. J. Immunol. 184:2 (2010), 582–590.
183. Watson, J.D., Origin of concatemeric T7 DNA. Nat. New Biol. 239:94 (1972), 197–201.
184. Wiley, C.D., Velarde, M.C. et al., Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23:2 (2016), 303–314.
185. Williams, G.C., Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:4 (1957), 398–411.
186. Wong, L.S., Oeseburg, H. et al., Telomere biology in cardiovascular disease: the TERC −/− mouse as a model for heart failure and ageing. Cardiovasc. Res. 81:2 (2009), 244–252.
187. Wu, Z., Puigserver, P. et al., Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:1 (1999), 115–124.
188. Wyllie, F.S., Jones, C.J. et al., Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24:1 (2000), 16–17.
189. Xiao, C.Y., Chen, M. et al., Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J. Pharmacol. Exp. Ther. 312:3 (2005), 891–898.
190. Xu, M., Palmer, A.K. et al., Targeting senescent cells enhances adipogenesis and metabolic function in old age. elife, 4, 2015, e12997.
191. Xue, W., Zender, L. et al., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:7128 (2007), 656–660.
192. Yang, W., Hekimi, S., A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol., 8(12), 2010, e1000556.
193. Yndestad, A., Neurauter, C.G. et al., Up-regulation of myocardial DNA base excision repair activities in experimental heart failure. Mutat. Res. 666:1–2 (2009), 32–38.
194. Youdim, M.B., Bakhle, Y.S., Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br. J. Pharmacol. 147:Suppl. 1 (2006), S287–296.
195. Zhu, X., Zuo, L., Characterization of oxygen radical formation mechanism at early cardiac ischemia. Cell Death Dis., 4, 2013, e787.
196. Zhu, Y., Tchkonia, T. et al., The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14:4 (2015), 644–658.